1. FDA sees only slight dip in device approvals during pandemic — Novartis' Novartis to provide 'no profit' COVID drugs to low income countries — Relay Therapeutics prices IPO at $400M — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Smith & Nephew

Anonymous board for Smith & Nephew


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    7
    Views:
    1,881
  2. anonymous
    Replies:
    21
    Views:
    11,684
  3. anonymous
    Replies:
    7
    Views:
    2,887
  4. anonymous
    Replies:
    38
    Views:
    18,509
  5. anonymous
    Replies:
    5
    Views:
    1,421
  6. Namal come back
    Replies:
    12
    Views:
    3,142
  7. anonymous
    Replies:
    13
    Views:
    2,913
  8. anonymous
    Replies:
    4
    Views:
    1,458
  9. anonymous
    Replies:
    20
    Views:
    5,082
  10. anonymous
    Replies:
    13
    Views:
    2,861
  11. anonymous
    Replies:
    15
    Views:
    2,673
  12. anonymous
    Replies:
    38
    Views:
    7,826
  13. anonymous
    Replies:
    1
    Views:
    2,085
  14. anonymous
    Replies:
    18
    Views:
    4,480
  15. anonymous
    Replies:
    46
    Views:
    21,772
  16. anonymous
    Replies:
    6
    Views:
    1,369
  17. anonymous
    Replies:
    0
    Views:
    1,201
  18. ....
    Replies:
    28
    Views:
    8,279
  19. anonymous
    Replies:
    10
    Views:
    4,341
  20. anonymous
    Replies:
    2
    Views:
    3,175

Thread Display Options

Loading...